TWEAK and Fn14 in the Neurovascular Unit

Area of Science:

• Neuroscience
• Cell Biology
• Pathology

Background:

• The neurovascular unit (NVU) comprises endothelial cells, basement membrane, astrocytes, pericytes, and neurons, crucial for brain homeostasis.
• The blood-brain barrier (BBB), a key function of the NVU, controls substance and cell passage into the brain parenchyma.
• Tumor necrosis factor-like weak inducer of apoptosis (TWEAK) and its receptor fibroblast growth factor-inducible 14 (Fn14) are expressed in the NVU.

Purpose of the Study:

• To review the role of the TWEAK-Fn14 interaction in regulating BBB function post-ischemic/hypoxic injury.
• To highlight the therapeutic potential of inhibiting the TWEAK-Fn14 pathway for neurological diseases.

Main Methods:

• Review of existing data on the TWEAK-Fn14 pathway in the NVU.
• Analysis of the impact of TWEAK-Fn14 signaling on BBB integrity and function.
• Evaluation of pharmacological inhibition strategies for TWEAK-Fn14.

Main Results:

• The TWEAK-Fn14 interaction at the endothelial cell-basement membrane-astrocyte interface modulates BBB function after ischemic/hypoxic events.
• Evidence suggests that TWEAK-Fn14 signaling is a critical regulator of BBB integrity in the context of brain injury.
• Pharmacological inhibition of TWEAK-Fn14 demonstrates potential for neuroprotection.

Conclusions:

• The TWEAK-Fn14 axis is a key regulator of BBB function following ischemic/hypoxic brain injury.
• Targeting the TWEAK-Fn14 pathway represents a promising therapeutic strategy for neurological disorders affecting the NVU.
• Further research into TWEAK-Fn14 inhibition could lead to novel treatments for stroke and other neurological conditions.